Diabetes Drugs Avandia (rosiglitazone) And Actos (pioglitazone) Have Same Heart Disease And Death Risks
Posted on August 25th, 2010 by Health News
A new analysis of diabetes medications Avandia (rosiglitazone) and Actos (pioglitazone) revealed that the risk of heart attack and/or heart failure, or death were the same, approximately 4%. The study has been published in the latest issue of Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal. Takeda Pharmacuetical Co…
Filed under: Pharmacy News
Tags: Drug, Heart disease, Pharmacy

Leave a Reply